Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 333 followers

Latest posts

Last updated about 1 hour ago

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026

about 1 hour ago

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)...

Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application withdrawn

about 1 hour ago

Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application...

Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Status: Opinion

about 1 hour ago

Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Status: Opinion

Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Status: Opinion

about 1 hour ago

Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Status: Opinion

First oral medicine targeting interleukin-23 receptor recommended for plaque psoriasis

about 1 hour ago

First oral medicine targeting interleukin-23 receptor recommended for plaque psoriasis

New treatment option for neovascular age-related macular degeneration

about 1 hour ago

New treatment option for neovascular age-related macular degeneration

Human medicines European public assessment report (EPAR): Riociguat Accord, riociguat, Status: Opinion

4 days ago

Human medicines European public assessment report (EPAR): Riociguat Accord, riociguat, Status: Opinion

Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Status: Opinion

4 days ago

Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Status...

Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Status: Opinion

4 days ago

Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Status: Opinion

Withdrawn application: Dupixent, 24/06/2026

1 day ago

Withdrawn application: Dupixent, 24/06/2026

Summary of opinion: Trodelvy, 23/07/2026 Positive

1 day ago

Summary of opinion: Trodelvy, 23/07/2026 Positive

Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion

about 1 hour ago

Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion